Article
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.
Breast cancer research and treatment - 1 Jul 2024
Assad Hadeel, Levitin Maria, Petrucelli Nancie, Manning Mark, Thompson Hayley S, Chen Wei, Jang Hyejeong, Simon Michael S
Abstract excerpt
PURPOSE: Carriers of pathogenic variants in BRCA1/2 have an elevated lifetime cancer risk warranting high-risk screening and risk-reducing procedures for early detection and prevention. We report on prevention practices among women with pathogenic BRCA variants in order to document follow through with NCCN recommendations and to identify barriers to guideline-recommended care. METHODS: Our cohort included women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.